Date | Insider | Price | Amount |
---|---|---|---|
11-14-2023 Insider Buy |
ARCH Venture Partners XII, LLC >10% Owner |
$11.77 CAGR » |
$412,139.61 35,010 shares |
11-14-2023 Insider Buy |
Kristina Burow Director and >10% Owner |
$11.77 CAGR » |
$412,139.61 35,010 shares |
11-10-2023 Insider Buy |
ARCH Venture Partners XII, LLC >10% Owner |
$10.98 CAGR » |
$1,543,563.42 140,605 shares |
11-10-2023 Insider Buy |
Kristina Burow Director and >10% Owner |
$10.98 CAGR » |
$1,543,563.42 140,605 shares |
11-7-2023 Insider Buy |
ARCH Venture Partners XII, LLC >10% Owner |
$11.49 CAGR » |
$1,099,944.70 95,694 shares |
11-7-2023 Insider Buy |
Kristina Burow Director and >10% Owner |
$11.49 CAGR » |
$1,099,944.70 95,694 shares |
9-29-2023 Insider Buy |
ARCH Venture Partners XII, LLC >10% Owner |
$13.68 CAGR » |
$1,046,848.16 76,511 shares |
9-29-2023 Insider Buy |
Kristina Burow Director and >10% Owner |
$13.68 CAGR » |
$1,046,848.16 76,511 shares |
9-27-2023 Insider Buy |
ARCH Venture Partners XII, LLC >10% Owner |
$11.97 CAGR » |
$700,464.24 58,504 shares |
9-27-2023 Insider Buy |
Kristina Burow Director and >10% Owner |
$11.97 CAGR » |
$700,464.24 58,504 shares |
9-25-2023 Insider Buy |
Kristina Burow Director and >10% Owner |
$11.19 CAGR » |
$1,127,063.95 100,740 shares |
9-25-2023 Insider Buy |
ARCH Venture Partners XII, LLC >10% Owner |
$11.19 CAGR » |
$1,127,063.95 100,740 shares |
9-19-2023 Insider Buy |
ARCH Venture Partners X, LLC >10% Owner |
$17.00 CAGR » |
$25,500,000.00 1,500,000 shares |
9-19-2023 Insider Buy |
Kristina Burow |
$17.00 CAGR » |
$25,500,000.00 1,500,000 shares |
9-19-2023 Insider Buy |
Henry O. Gosebruch President & CEO |
$12.62 CAGR » |
$189,370.50 15,000 shares |
9-19-2023 Insider Buy |
Inc Amgen |
$17.00 CAGR » |
$29,999,985.00 1,764,705 shares |
Also See: Institutional Holders of NMRA
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/15/2023 | |
End date: | 05/06/2024 | |
Start price/share: | $12.01 | |
End price/share: | $9.35 | |
Dividends collected/share: | $0.00 | |
Total return: | -22.15% | |
Annualized Gain: | -47.00% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,785.00 | |
Years: | 0.47 |
Neumora Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Neumora Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NMRA
Free NMRA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Neumora Therapeutics Insider Buying occurred are:
Mettler-Toledo International Insider Buying |